vs

Side-by-side financial comparison of Cboe Global Markets (CBOE) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Cboe Global Markets is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.3× Everus Construction Group, Inc.). Cboe Global Markets runs the higher net margin — 30.3% vs 5.5%, a 24.8% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 6.5%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 14.3%).

Cboe Global Markets, Inc. is an American financial exchange operator headquartered in Chicago. It owns and operates a portfolio of exchanges and trading venues across equities, options, futures, and digital assets.

CBOE vs ECG — Head-to-Head

Bigger by revenue
CBOE
CBOE
1.3× larger
CBOE
$1.3B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+26.6% gap
ECG
33.2%
6.5%
CBOE
Higher net margin
CBOE
CBOE
24.8% more per $
CBOE
30.3%
5.5%
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
14.3%
CBOE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBOE
CBOE
ECG
ECG
Revenue
$1.3B
$1.0B
Net Profit
$385.7M
$55.3M
Gross Margin
57.3%
11.6%
Operating Margin
39.7%
6.8%
Net Margin
30.3%
5.5%
Revenue YoY
6.5%
33.2%
Net Profit YoY
53.9%
60.4%
EPS (diluted)
$3.66
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBOE
CBOE
ECG
ECG
Q1 26
$1.3B
Q4 25
$1.2B
$1.0B
Q3 25
$1.1B
$986.8M
Q2 25
$1.2B
$921.5M
Q1 25
$1.2B
$826.6M
Q4 24
$1.1B
$759.6M
Q3 24
$1.1B
$761.0M
Q2 24
$974.0M
$703.4M
Net Profit
CBOE
CBOE
ECG
ECG
Q1 26
$385.7M
Q4 25
$313.5M
$55.3M
Q3 25
$300.8M
$57.0M
Q2 25
$235.1M
$52.8M
Q1 25
$250.6M
$36.7M
Q4 24
$196.5M
$34.5M
Q3 24
$218.5M
$41.8M
Q2 24
$140.4M
$39.0M
Gross Margin
CBOE
CBOE
ECG
ECG
Q1 26
57.3%
Q4 25
55.7%
11.6%
Q3 25
53.0%
12.6%
Q2 25
50.0%
13.0%
Q1 25
47.3%
11.2%
Q4 24
47.4%
11.4%
Q3 24
50.4%
11.8%
Q2 24
52.8%
12.6%
Operating Margin
CBOE
CBOE
ECG
ECG
Q1 26
39.7%
Q4 25
33.5%
6.8%
Q3 25
32.4%
7.3%
Q2 25
28.9%
7.9%
Q1 25
29.6%
6.2%
Q4 24
27.0%
6.1%
Q3 24
29.1%
7.1%
Q2 24
21.6%
7.3%
Net Margin
CBOE
CBOE
ECG
ECG
Q1 26
30.3%
Q4 25
26.0%
5.5%
Q3 25
26.3%
5.8%
Q2 25
20.0%
5.7%
Q1 25
21.0%
4.4%
Q4 24
17.7%
4.5%
Q3 24
20.7%
5.5%
Q2 24
14.4%
5.5%
EPS (diluted)
CBOE
CBOE
ECG
ECG
Q1 26
$3.66
Q4 25
$2.97
$1.09
Q3 25
$2.85
$1.11
Q2 25
$2.23
$1.03
Q1 25
$2.37
$0.72
Q4 24
$1.85
$0.68
Q3 24
$2.07
$0.82
Q2 24
$1.33
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBOE
CBOE
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$2.1B
Total DebtLower is stronger
$1.4B
$281.5M
Stockholders' EquityBook value
$5.4B
$629.8M
Total Assets
$11.1B
$1.7B
Debt / EquityLower = less leverage
0.27×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBOE
CBOE
ECG
ECG
Q1 26
$2.1B
Q4 25
$2.3B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.2B
Q4 24
$1.0B
Q3 24
$763.2M
$553.0K
Q2 24
$698.3M
Total Debt
CBOE
CBOE
ECG
ECG
Q1 26
$1.4B
Q4 25
$1.4B
$281.5M
Q3 25
$1.4B
$285.1M
Q2 25
$1.4B
$288.6M
Q1 25
$1.4B
$292.1M
Q4 24
$1.4B
$295.6M
Q3 24
$1.4B
Q2 24
$1.4B
Stockholders' Equity
CBOE
CBOE
ECG
ECG
Q1 26
$5.4B
Q4 25
$5.1B
$629.8M
Q3 25
$4.9B
$573.0M
Q2 25
$4.7B
$514.4M
Q1 25
$4.5B
$460.2M
Q4 24
$4.3B
$422.6M
Q3 24
$4.2B
$453.3M
Q2 24
$4.0B
$490.0M
Total Assets
CBOE
CBOE
ECG
ECG
Q1 26
$11.1B
Q4 25
$9.3B
$1.7B
Q3 25
$9.1B
$1.6B
Q2 25
$9.0B
$1.5B
Q1 25
$8.7B
$1.4B
Q4 24
$7.8B
$1.3B
Q3 24
$8.7B
$1.3B
Q2 24
$9.3B
Debt / Equity
CBOE
CBOE
ECG
ECG
Q1 26
0.27×
Q4 25
0.28×
0.45×
Q3 25
0.30×
0.50×
Q2 25
0.31×
0.56×
Q1 25
0.32×
0.63×
Q4 24
0.34×
0.70×
Q3 24
0.34×
Q2 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBOE
CBOE
ECG
ECG
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBOE
CBOE
ECG
ECG
Q1 26
Q4 25
$352.1M
$48.2M
Q3 25
$153.9M
$76.2M
Q2 25
$333.7M
$25.3M
Q1 25
$912.9M
$7.1M
Q4 24
$-710.4M
Q3 24
$-578.5M
$78.9M
Q2 24
$1.5B
Free Cash Flow
CBOE
CBOE
ECG
ECG
Q1 26
Q4 25
$332.1M
$23.5M
Q3 25
$137.9M
$65.7M
Q2 25
$313.4M
$12.3M
Q1 25
$898.2M
$-11.4M
Q4 24
$-734.2M
Q3 24
$-590.5M
$60.9M
Q2 24
$1.5B
FCF Margin
CBOE
CBOE
ECG
ECG
Q1 26
Q4 25
27.6%
2.3%
Q3 25
12.1%
6.7%
Q2 25
26.7%
1.3%
Q1 25
75.2%
-1.4%
Q4 24
-66.3%
Q3 24
-55.9%
8.0%
Q2 24
151.6%
Capex Intensity
CBOE
CBOE
ECG
ECG
Q1 26
Q4 25
1.7%
2.4%
Q3 25
1.4%
1.1%
Q2 25
1.7%
1.4%
Q1 25
1.2%
2.2%
Q4 24
2.1%
Q3 24
1.1%
2.4%
Q2 24
1.8%
Cash Conversion
CBOE
CBOE
ECG
ECG
Q1 26
Q4 25
1.12×
0.87×
Q3 25
0.51×
1.34×
Q2 25
1.42×
0.48×
Q1 25
3.64×
0.19×
Q4 24
-3.62×
Q3 24
-2.65×
1.89×
Q2 24
10.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBOE
CBOE

Derivatives markets$609.3M48%
Cash and spot markets$482.2M38%
Data Vantage$181.3M14%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons